OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Echinacoside Protects Dopaminergic Neurons Through Regulating IL-6/JAK2/STAT3 Pathway in Parkinson’s Disease Model
Xueping Yang, Qingyun Yv, Fanlong Ye, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 27

Showing 1-25 of 27 citing articles:

JAK2/STAT3 as a new potential target to manage neurodegenerative diseases: An interactive review
Siva Prasad Panda, Adarsh Kesharwani, Samaresh Datta, et al.
European Journal of Pharmacology (2024) Vol. 970, pp. 176490-176490
Closed Access | Times Cited: 14

The Role of IL-6 in Neurodegenerative Disorders
Chen Shan, Chao Zhang, Chuanbao Zhang
Neurochemical Research (2024) Vol. 49, Iss. 4, pp. 834-846
Closed Access | Times Cited: 11

Echinacoside: A promising active natural products and pharmacological agents
Wang Wang, Shujun Jiang, Yang Zhao, et al.
Pharmacological Research (2023) Vol. 197, pp. 106951-106951
Open Access | Times Cited: 19

Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 6

Jiawei Kongsheng Zhenzhong Pill: marker compounds, absorption into the serum (rat), and Q-markers identified by UPLC-Q-TOF-MS/MS
Qiaolan Wu, Chunxue Ou, Jiayun Wang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 5

Medicinal and food plant: Cistanches Herba, a potential therapeutic hope for Parkinson’s disease and related complications
Guoxue Zhu, Chengcheng Xu, Shujun Jiang, et al.
Journal of Agriculture and Food Research (2025), pp. 101671-101671
Open Access

Navigating the Complexities of Neuronal Signaling and Targets in Neurological Disorders: From Pathology to Therapeutics
Divya Choudhary, Muhammad Imran Khan, Zuber Khan, et al.
European Journal of Pharmacology (2025), pp. 177417-177417
Closed Access

Role of Plant-Derived Compounds in the Molecular Pathways Related to Inflammation
Agata J. Olędzka, Monika E. Czerwińska
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 5, pp. 4666-4666
Open Access | Times Cited: 11

Single-cell RNA-sequencing analysis reveals α-syn induced astrocyte-neuron crosstalk-mediated neurotoxicity
Kuan Li, Haosen Ling, Weimin Huang, et al.
International Immunopharmacology (2024) Vol. 139, pp. 112676-112676
Closed Access | Times Cited: 3

Targeting mitochondria with small molecules: A promising strategy for combating Parkinson’s disease
Chinmay Pal
Mitochondrion (2024), pp. 101971-101971
Closed Access | Times Cited: 3

Cistanche tubulosa alleviates ischemic stroke-induced blood-brain barrier damage by modulating microglia-mediated neuroinflammation
Yucheng Liao, Jingwen Wang, Chao Guo, et al.
Journal of Ethnopharmacology (2023) Vol. 309, pp. 116269-116269
Closed Access | Times Cited: 9

The gut microbiota metabolite butyrate mitigates MPTP/MPP+‐induced Parkinson's disease by inhibiting the JAK2/STAT3 signaling pathway
Lili Ji, Tingting Huang, Lun‐Lin Mao, et al.
The Kaohsiung Journal of Medical Sciences (2023) Vol. 39, Iss. 10, pp. 1002-1010
Open Access | Times Cited: 6

Echinacoside exerts neuroprotection via suppressing microglial α-synuclein/TLR2/NF-κB/NLRP3 axis in parkinsonian models
Xueping Yang, Jia-Hua Huang, Fanlong Ye, et al.
Phytomedicine (2023) Vol. 123, pp. 155230-155230
Closed Access | Times Cited: 6

Beneficial Effects of Echinacoside on Cognitive Impairment and Diabetes in Type 2 Diabetic db/db Mice
Fanglin Qin, Yiming Yan, Ningxi Yang, et al.
Experimental and Clinical Endocrinology & Diabetes (2024) Vol. 132, Iss. 08, pp. 420-430
Open Access | Times Cited: 1

Correlations of gray matter volume with peripheral cytokines in Parkinson's disease
BaoLing Chen, Hang Zhou, XinZi Liu, et al.
Neurobiology of Disease (2024) Vol. 201, pp. 106693-106693
Open Access | Times Cited: 1

2-Acetylacteoside improves recovery after ischemic stroke by promoting neurogenesis via the PI3K/Akt pathway
Meng Wang, Songyu Xing, Yang Liu, et al.
Free Radical Biology and Medicine (2024) Vol. 225, pp. 415-429
Closed Access | Times Cited: 1

Folic acid deficiency exacerbates the inflammatory response of astrocytes after ischemia‐reperfusion by enhancing the interaction between IL‐6 and JAK‐1/pSTAT3
Man Cheng, Xiaoshan Liang, Linran Shi, et al.
CNS Neuroscience & Therapeutics (2023) Vol. 29, Iss. 6, pp. 1537-1546
Open Access | Times Cited: 4

Transcriptome sequencing and network pharmacology-based approach to reveal the effect and mechanism of Ji Chuan Jian against Parkinson’s disease
Yao Wu, Yu Bai, Yan Lu, et al.
BMC Complementary Medicine and Therapies (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 4

Effects of Echinacoside on Ehrlich Carcinoma in Rats by Targeting Proliferation, Hypoxia and Inflammation
Afnan Alshehri, Aeshah H AlBuhayri, May Naif Alanazi, et al.
Cureus (2023)
Open Access | Times Cited: 4

The potential effects and mechanism of echinacoside powder in the treatment of Hirschsprung's Disease
Enyang He, Yuhang Jiang, Diwei Wei, et al.
Mathematical Biosciences & Engineering (2023) Vol. 20, Iss. 8, pp. 14222-14240
Open Access | Times Cited: 2

A systematic review of the traditional uses, chemistry, and curative aptitude of echinacoside—a phenylethanoid glycoside
Ritika Baidya, Biswatrish Sarkar
Naunyn-Schmiedeberg s Archives of Pharmacology (2024)
Closed Access

Neuroprotective Effect of Echinoside on MPTP-induced Parkinson's Disease Mouse Model by Activation of NRF2/HO-1 Pathway
Zimeng Li, Hongyan Li
Pharmacological Research - Modern Chinese Medicine (2024) Vol. 13, pp. 100525-100525
Open Access

Page 1 - Next Page

Scroll to top